BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38414316)

  • 1. Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
    Ohtaki Y; Nagashima T; Okano N; Kubo N; Ohtaka T; Sunaga N; Sakurai R; Miura Y; Nakazawa S; Kawatani N; Yazawa T; Yoshikawa R; Narusawa E; Shirabe K
    Thorac Cancer; 2024 Apr; 15(11):859-866. PubMed ID: 38414316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of failure and clinical value of local therapy for oligo-recurrence in locally advanced non-small cell lung cancer after definitive chemoradiation: Impact of driver mutation status.
    Zhang J; Mao J; Xu D; Jiang S; Guo T; Zhou Y; Chu L; Yang X; Chu X; Ni J; Zhu Z
    Cancer Med; 2023 Mar; 12(6):6971-6979. PubMed ID: 36524618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations.
    Deng Q; Wang H; Xiu W; Tian X; Gong Y
    Jpn J Radiol; 2023 May; 41(5):551-560. PubMed ID: 36484979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt.
    Bahnassy AA; Ismail H; Mohanad M; El-Bastawisy A; Yousef HF
    J Egypt Natl Canc Inst; 2022 May; 34(1):23. PubMed ID: 35644823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung Cancer.
    Nakamura M; Ohnishi K; Ishikawa H; Nakazawa K; Shiozawa T; Okumura T; Sekine I; Sato Y; Hizawa N; Sakurai H
    In Vivo; 2020; 34(4):1883-1892. PubMed ID: 32606159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage radiotherapy for regional lymph node oligo-recurrence after radical surgery of non-small cell lung cancer.
    Seol KH; Lee JE; Cho JY; Lee DH; Seok Y; Kang MK
    Thorac Cancer; 2017 Nov; 8(6):620-629. PubMed ID: 28906073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of the highest mediastinal lymph node metastasis on postoperative recurrence and survival in non-small cell lung cancer patients].
    Liu JW; Zhang XN; Lin G; Li J
    Zhonghua Wai Ke Za Zhi; 2023 Dec; 61(12):1086-1092. PubMed ID: 37932145
    [No Abstract]   [Full Text] [Related]  

  • 11. Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.
    Shi Y; Lei Y; Liu L; Zhang S; Wang W; Zhao J; Zhao S; Dong X; Yao M; Wang K; Zhou Q
    Cancer Med; 2021 Apr; 10(7):2216-2231. PubMed ID: 33655698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of multi-level N2-positive non-small cell lung cancer according to lymph node staging using endobronchial ultrasound-transbronchial biopsy.
    Yoon HY; Lee JC; Kim SW; Kim HR; Kim YH; Choi SH; Kim SS; Song SY; Choi EK; Jang SJ; Choi CM
    Thorac Cancer; 2018 Jun; 9(6):684-692. PubMed ID: 29607613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
    Dong S; Zhao N; Deng W; Sun HW; Niu FY; Yang JJ; Zhong WZ; Li F; Yan HH; Xu CR; Zhang QY; Yang XN; Liao RQ; Nie Q; Wu YL
    World J Surg Oncol; 2017 Jan; 15(1):12. PubMed ID: 28069039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection-can local recurrence be radically cured by radiation?
    Terada Y; Isaka M; Harada H; Konno H; Kojima H; Mizuno T; Murayama S; Takahashi T; Ohde Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):425-433. PubMed ID: 31926488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
    Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
    Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for postoperative thoracic lymph node recurrence of non-small-cell lung cancer provides better outcomes if the disease is asymptomatic and a single-station involvement.
    Okami J; Nishiyama K; Fujiwara A; Konishi K; Kanou T; Tokunaga T; Teshima T; Higashiyama M
    J Thorac Oncol; 2013 Nov; 8(11):1417-24. PubMed ID: 24077458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung Cancer.
    Imai H; Onozato R; Kaira K; Kawashima S; Masubuchi K; Tajima K; Minato K
    Oncology; 2022; 100(2):89-100. PubMed ID: 34844253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
    Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Shaw EG; Marks RS; Frytak S; Lange CM; Li H
    Cancer; 1997 Oct; 80(8):1399-408. PubMed ID: 9338463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.